0001209191-22-008948.txt : 20220211
0001209191-22-008948.hdr.sgml : 20220211
20220211173321
ACCESSION NUMBER: 0001209191-22-008948
CONFORMED SUBMISSION TYPE: 5
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211231
FILED AS OF DATE: 20220211
DATE AS OF CHANGE: 20220211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Scopa James Paul
CENTRAL INDEX KEY: 0001356950
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40794
FILM NUMBER: 22623031
MAIL ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD
STREET 2: SUITE 350
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DICE Therapeutics, Inc.
CENTRAL INDEX KEY: 0001645569
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472286244
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 279 E. GRAND AVENUE, SUITE 300, LOBBY B
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-566-1402
MAIL ADDRESS:
STREET 1: 279 E. GRAND AVENUE, SUITE 300, LOBBY B
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: DiCE MOLECULES HOLDINGS, LLC
DATE OF NAME CHANGE: 20180725
FORMER COMPANY:
FORMER CONFORMED NAME: DiCE Molecules Holdings, LLC
DATE OF NAME CHANGE: 20150617
5
1
doc5.xml
FORM 5 SUBMISSION
X0306
5
2021-12-31
0
0
0
0001645569
DICE Therapeutics, Inc.
DICE
0001356950
Scopa James Paul
C/O DICE THERAPEUTICS, INC.
279 E. GRAND AVENUE, SUITE 300, LOBBY B
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Common Stock
2021-12-30
5
G
0
3000
0.00
D
52841
D
Common Stock
2021-12-30
5
G
0
3000
0.00
A
3000
I
By Trust
Represents shares of the Issuer's Common Stock that the Reporting Person transferred as a bona fide gift for no consideration, which shares have not been sold and remain subject to the lock-up agreement entered into in connection with the Issuer's initial public offering.
These securities are held of record by The James P. Scopa and Anne E. Kenner Family Trust, Anne E. Kenner and James P. Scopa, Trustees.
/s/ Scott Robertson as attorney-in-fact for James P. Scopa
2022-02-11